Michael Palmer is the Vice President of Translational Medicine at Relay Therapeutics and has held this position since 2024. Previously, from 2022 to 2024, they served as the Vice President of Translational Oncology at Bicycle Therapeutics. With extensive experience in the field, they have worked at notable organizations such as Blueprint Medicines, C4 Therapeutics, and Novartis, where they held roles including Director and Principal Scientist. Michael earned a PhD in Biology from The University of Kansas in 2000 and has contributed significantly to drug development and biomarker research throughout their career. In addition, they are currently a Director and Board Member at Sippican Lands Trust.
This person is not in the org chart
This person is not in any teams
This person is not in any offices